Species : |
Human |
Source : |
CHO |
Description : |
The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members bind heparin and possess broad mitogenic and angiogenic activities. This protein has been implicated in diverse biological processes, such as limb and nervous system development, wound healing, and tumor growth. The mRNA for this gene contains multiple polyadenylation sites, and is alternatively translated from non-AUG (CUG) and AUG initiation codons, resulting in five different isoforms with distinct properties. The CUG-initiated isoforms are localized in the nucleus and are responsible for the intracrine effect, whereas, the AUG-initiated form is mostly cytosolic and is responsible for the paracrine and autocrine effects of this FGF |
Form : |
Lyophilized powder |
Endotoxin : |
<20 EU/mg |
Bio-activity : |
>5.0 x 10^7 IU/mg |
Purity : |
>95.0% by high performance liquid chromatography (SEC-HPLC) and SDS-PAGE. |
Storage Buffer : |
10mM Phosphate-Buffered Saline (pH 7.2) |
Storage : |
Stable storage at 4℃ for 7-10 days; for long-term storage, please store at -20℃ after dispensing. |
Sterility : |
Sterility |
Instructions : |
It is recommended that lyophilized GMP rhFGF2 be dissolved in water for injection or sterilized ultrapure water at a concentration of not less than 100 μg/ml, pending further dilution to working concentration. |